Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections

Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection

(2016) Jason P. Burnham et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System

(2016) R. Brigg Turner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014

(2016) Lindsey M. Weiner et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Infectious disease consultation for Staphylococcus aureus bacteremia – A systematic review and meta-analysis

(2016) Monique Vogel et al.   JOURNAL OF INFECTION

A cohort study of bacteremic pneumonia

(2016) Cristina Vazquez Guillamet et al.   MEDICINE

Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study

(2015) Anthony D. Bai et al.   CLINICAL INFECTIOUS DISEASES

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation

(2015) Dimitrios Farmakiotis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study

(2014) Andrew F Shorr et al.   BMC INFECTIOUS DISEASES

Impact of Infectious Disease Consultation on the Clinical and Economic Outcomes of Solid Organ Transplant Recipients Admitted for Infectious Complications

(2014) Bassem Hamandi et al.   CLINICAL INFECTIOUS DISEASES

Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality

(2014) F. Tissot et al.   JOURNAL OF INFECTION

Using claims data to predict dependency in activities of daily living as a proxy for frailty

(2014) Keturah R. Faurot et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

(2014) Dilip Nathwani et al.   Antimicrobial Resistance and Infection Control

Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence

(2013) Giannoula S Tansarli et al.   Expert Review of Anti-Infective Therapy

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU

(2009) J. C. SHU et al.   EPIDEMIOLOGY AND INFECTION

Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital Cohort

(2009) Anne M. Butler et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples

(2009) Peter C. Austin   STATISTICS IN MEDICINE

Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria

(2008) Katherine E. Kollef et al.   CHEST